Search research articles
Contact Us
Filters
Showing results (41-50 of 85) with videos related to
Page
of 9
Sort By:
The Journal of Clinical Investigation
|
March 6, 2002
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
Ryan A Wilcox, Dallas B Flies, Gefeng Zhu, et al.
The Journal of Clinical Investigation
|
February 6, 2003
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Haidong Dong, Scott E Strome, Eric L Matteson, et al.
Gynecologic Oncology
|
April 16, 2003
Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy
Prema P Peethambaram, William A Cliby, Gregory Lubiniecki, et al.
Journal of Molecular Recognition : JMR
|
January 30, 2009
Epitope mapping of a chimeric CD137 mAb: a necessary step for assessing the biologic relevance of non-human primate models
Siaw-Lin Chan, Caroline J Voskens, Wei Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 29, 2013
Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma
Stephen R Goding, Kyle A Wilson, Ying Xie, et al.
Frontiers in Immunology
|
August 28, 2023
Fc multimers effectively treat murine models of multiple sclerosis
Jin Wang, Kellie Brown, Caroline Danehy, et al.
Cancer Research
|
September 10, 2009
Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas
Timothy Kottke, Jose Pulido, Jill Thompson, et al.
Cancer Immunology, Immunotherapy : CII
|
November 4, 2008
FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck
Rodney J Taylor, Siaw-Lin Chan, Aaron Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo
Jeffrey S Wolf, Guoyan Li, Atul Varadhachary, et al.
Cancer Research
|
May 3, 2011
Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010
Hildegund C J Ertl, John Zaia, Steven A Rosenberg, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 85) with videos related to
Sort By:
Page
of 9
The Journal of Clinical Investigation
|
March 6, 2002
Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors
Ryan A Wilcox, Dallas B Flies, Gefeng Zhu, et al.
The Journal of Clinical Investigation
|
February 6, 2003
Costimulating aberrant T cell responses by B7-H1 autoantibodies in rheumatoid arthritis
Haidong Dong, Scott E Strome, Eric L Matteson, et al.
Gynecologic Oncology
|
April 16, 2003
Her-2/neu expression in ovarian cancer: pre- and postexposure to platinum chemotherapy
Prema P Peethambaram, William A Cliby, Gregory Lubiniecki, et al.
Journal of Molecular Recognition : JMR
|
January 30, 2009
Epitope mapping of a chimeric CD137 mAb: a necessary step for assessing the biologic relevance of non-human primate models
Siaw-Lin Chan, Caroline J Voskens, Wei Lin, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
March 29, 2013
Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma
Stephen R Goding, Kyle A Wilson, Ying Xie, et al.
Frontiers in Immunology
|
August 28, 2023
Fc multimers effectively treat murine models of multiple sclerosis
Jin Wang, Kellie Brown, Caroline Danehy, et al.
Cancer Research
|
September 10, 2009
Antitumor immunity can be uncoupled from autoimmunity following heat shock protein 70-mediated inflammatory killing of normal pancreas
Timothy Kottke, Jose Pulido, Jill Thompson, et al.
Cancer Immunology, Immunotherapy : CII
|
November 4, 2008
FcgammaRIIIa polymorphisms and cetuximab induced cytotoxicity in squamous cell carcinoma of the head and neck
Rodney J Taylor, Siaw-Lin Chan, Aaron Wood, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 3, 2007
Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo
Jeffrey S Wolf, Guoyan Li, Atul Varadhachary, et al.
Cancer Research
|
May 3, 2011
Considerations for the clinical application of chimeric antigen receptor T cells: observations from a recombinant DNA Advisory Committee Symposium held June 15, 2010
Hildegund C J Ertl, John Zaia, Steven A Rosenberg, et al.
Page
of 9